Roche Receives CE Mark for Rapid Elecsys IGRA TB Test to Detect Latent Tuberculosis

Shots: Roche has received a CE Mark for its Elecsys IGRA TB test, a blood-based assay for detecting tuberculosis infection (latent TB) in routine laboratory settings Test delivers results in <24hrs., with IGRA assay completed in 19min., & automates result calculation, interpretation, & reporting on Roche immunoassay platforms while integrating with third-party liquid handlers to streamline laboratory workflows In a global study, Elecsys IGRA TB demonstrated 91.1% PPA & 94.6% NPA in the intended-use population, plus 100% relative sensitivity in confirmed TB cases, & 95.3% specificity in low-risk individuals Ref: Globenewswire |  Image: Roche  | Press Release Related News: Roche’s Elecsys pTau217 Test Receives the European CE Mark Approval to Rule in or Rule Out Alzheimer’s-Related Amyloid Pathology PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Roche Receives CE Mark for Rapid Elecsys IGRA TB Test to Detect Latent Tuberculosis appeared first on PharmaShots.